Biopharmaceutical Contract Manufacturing / Biomanufacturing Services

Genezen, Galibra Partner on SSADH Gene Therapy
Thursday, October 15, 2026
Genezen and Galibra Neuroscience have entered a manufacturing partnership to prepare Galibra’s experimental gene therapy for succinic semialdehyde dehydrogenase deficiency for a planned first human trial. read more
Charles River, Magellan Partner on Zelestrocel Testing
Thursday, October 15, 2026
Charles River Laboratories has agreed to provide testing and development services to Magellan Stem Cells as the Australian biotechnology company prepares a Phase III program for its experimental osteoarthritis treatment, Zelestrocel. Financial terms were not disclosed. read more
Perceptive, Nucleus Form Radiopharmaceutical Partnership
Thursday, October 15, 2026
Perceptive Discovery and Nucleus RadioPharma have formed a nonexclusive partnership linking preclinical testing with clinical manufacturing for radiopharmaceutical developers. read more
Lonza Expands Six-Month Biologics Development Offering
Thursday, October 15, 2026
Lonza has expanded its development and manufacturing offering to include more complex biologic medicines, with a stated goal of preparing some programs for Investigational New Drug applications in as little as six months. read more
Southern Research Gets $8 Million NIH Grant
Tuesday, October 13, 2026
Southern Research has received an $8 million National Institutes of Health grant to build a shared-use biomedical research facility focused on developing and validating methods that reduce reliance on animal testing in drug discovery and development. read more

More News

A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
Pharma Flash - Layoffs and Mergers & Acquisitions - Plus Long COVID Study ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: In this week’s Pharma Flash – Emergent cuts business operations and reduces headcount. PrecisionLife releases COVID study results and Lilly and Regeneron...